Hims & Hers Health ( ($HIMS) ) has risen by 21.11%. Read on to learn why. Hims & Hers Health has experienced a notable 21.11% ...

We recently published 10 Stocks With Eye-Popping Double-Digit Gains. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the ...

Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high on no company news. While it is revolutionizing access to healthcare by ...

THEY have taken the nation’s waistlines by storm, helping thousands shed pounds and trim inches. So-called fat jabs have been dubbed a “miracle” – helping turn the tide on ...

The more cautious voices point to Hims’s high P/E ratio and recent volatility, warning that the stock could cool off after its sharp run-up. That said, a few analysts are still pretty optimistic. They ...

HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.

Everything you need to know about Ted Lasso season four, starring Jason Sudeikis and Hannah Waddingham, plus the latest news about the cast returning!

A MOTHER has revealed that she has been battling “crazy” cravings for years – and it’s not due to being pregnant. Yaz Chapman ...

The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion Entry to Canada will come as generic semaglutide hits the market for the first time, marking a major ...

With ZAVA now part of Hims & Hers, the company is scaling care across markets where its comprehensive offerings can meet consumer needs. The plans for Canada entry reflect continued progress on a ...